6 completed, 1 not yet recruiting, 1 suspended, 1 unknown. 5 Phase 3, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 1, Suspended 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Esophagitis, Reflux: new trials by email Literature Review of Esophagitis, Reflux trials Research Report on Esophagitis, Reflux
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Reconstruction After Proximal Gastrectomy left-opening single-flap technique, double-flap group technique - Esophagitis, Reflux | Not applicable | Not yet recruiting | Oncogastroenterology Committee of Chinese | 250 | 2022-08-01 | 2022-07-05 |
| To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis Z-215 10mg, Z-215 20mg, Z-215 Placebo - Esophagitis, Reflux | Phase 2 | Completed | Zeria Pharmaceutical | 503 | 2015-05-01 | 2017-07-02 |
| Assessment of GERD Knowledge Level Among Patients With it in Korea Esophagitis, Reflux | Unknown | Chuncheon Sacred Heart Hospital | 1000 | 2014-04-01 | 2014-04-07 | |
| Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis Dexlansoprazole MR, Placebo - Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Completed | Takeda | 445 | 2006-05-01 | 2012-02-03 |
| Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis S-Tenatoprazole-Na (STU-Na) - Esophagitis, Reflux | Phase 2 | Suspended | STEBA France | 450 | 2006-02-01 | 2008-03-19 |
| Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis Dexlansoprazole MR, Placebo - Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Completed | Takeda | 451 | 2006-01-01 | 2012-02-03 |
| Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis Dexlansoprazole MR, Placebo - Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Completed | Takeda | 451 | 2006-01-01 | 2012-02-03 |
| Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis Dexlansoprazole MR, Lansoprazole - Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Completed | Takeda | 2038 | 2005-12-01 | 2012-02-03 |
| Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis Dexlansoprazole MR, Lansoprazole - Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Completed | Takeda | 2054 | 2005-12-01 | 2012-02-03 |
Esophagitis, Peptic (9) · Gastroesophageal Reflux (1) · Heartburn (1)
Digestive System Diseases (9) · Duodenal Diseases (9) · Esophageal Diseases (9) · Esophagitis (9) · Gastroenteritis (9) · Gastrointestinal Diseases (9) · Intestinal Diseases (9) · Peptic Ulcer (9) · Stomach Diseases (9) · Deglutition Disorders (1) · Esophageal Motility Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Dexlansoprazole (5) · Lansoprazole (5) · Rabeprazole (1)
Takeda (5) · Chuncheon Sacred Heart Hospital (1) · Oncogastroenterology Committee of Chinese (1) · STEBA France (1) · Zeria Pharmaceutical (1)
United States (5) · Canada (4) · Australia (3) · Czechia (3) · Latvia (3) · Lithuania (3) · Slovakia (3) · Bulgaria (2) · Germany (2) · India (2) · New Zealand (2) · Peru (2) · Poland (2) · South Africa (2) · Colombia (1)
Alan Thomson, MD, Prof. (1) · Chao Zhang, MD (1) · Junjun She, MD (1) · Lei Wang, MD (1) · Moo In Park, MD (1) · Nan Wang, MD (1) · Renwei Chang, MD (1)
PMID 19735233, PMID 20195905, PMID 21129076, PMID 19183157, PMID 19681809, PMID 23451835, PMID 24118079, PMID 19210298, PMID 36465382